358 related articles for article (PubMed ID: 25786782)
1. Hepatocyte-specific delivery of siRNAs conjugated to novel non-nucleosidic trivalent N-acetylgalactosamine elicits robust gene silencing in vivo.
Rajeev KG; Nair JK; Jayaraman M; Charisse K; Taneja N; O'Shea J; Willoughby JL; Yucius K; Nguyen T; Shulga-Morskaya S; Milstein S; Liebow A; Querbes W; Borodovsky A; Fitzgerald K; Maier MA; Manoharan M
Chembiochem; 2015 Apr; 16(6):903-8. PubMed ID: 25786782
[TBL] [Abstract][Full Text] [Related]
2. siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytes.
Matsuda S; Keiser K; Nair JK; Charisse K; Manoharan RM; Kretschmer P; Peng CG; V Kel'in A; Kandasamy P; Willoughby JL; Liebow A; Querbes W; Yucius K; Nguyen T; Milstein S; Maier MA; Rajeev KG; Manoharan M
ACS Chem Biol; 2015 May; 10(5):1181-7. PubMed ID: 25730476
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression.
Willoughby JLS; Chan A; Sehgal A; Butler JS; Nair JK; Racie T; Shulga-Morskaya S; Nguyen T; Qian K; Yucius K; Charisse K; van Berkel TJC; Manoharan M; Rajeev KG; Maier MA; Jadhav V; Zimmermann TS
Mol Ther; 2018 Jan; 26(1):105-114. PubMed ID: 28988716
[TBL] [Abstract][Full Text] [Related]
4. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing.
Nair JK; Willoughby JL; Chan A; Charisse K; Alam MR; Wang Q; Hoekstra M; Kandasamy P; Kel'in AV; Milstein S; Taneja N; O'Shea J; Shaikh S; Zhang L; van der Sluis RJ; Jung ME; Akinc A; Hutabarat R; Kuchimanchi S; Fitzgerald K; Zimmermann T; van Berkel TJ; Maier MA; Rajeev KG; Manoharan M
J Am Chem Soc; 2014 Dec; 136(49):16958-61. PubMed ID: 25434769
[TBL] [Abstract][Full Text] [Related]
5. Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate.
Zimmermann TS; Karsten V; Chan A; Chiesa J; Boyce M; Bettencourt BR; Hutabarat R; Nochur S; Vaishnaw A; Gollob J
Mol Ther; 2017 Jan; 25(1):71-78. PubMed ID: 28129130
[TBL] [Abstract][Full Text] [Related]
6. Novel Cluster and Monomer-Based GalNAc Structures Induce Effective Uptake of siRNAs in Vitro and in Vivo.
Sharma VK; Osborn MF; Hassler MR; Echeverria D; Ly S; Ulashchik EA; Martynenko-Makaev YV; Shmanai VV; Zatsepin TS; Khvorova A; Watts JK
Bioconjug Chem; 2018 Jul; 29(7):2478-2488. PubMed ID: 29898368
[TBL] [Abstract][Full Text] [Related]
7. Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways.
Kandasamy P; Mori S; Matsuda S; Erande N; Datta D; Willoughby JLS; Taneja N; O'Shea J; Bisbe A; Manoharan RM; Yucius K; Nguyen T; Indrakanti R; Gupta S; Gilbert JA; Racie T; Chan A; Liu J; Hutabarat R; Nair JK; Charisse K; Maier MA; Rajeev KG; Egli M; Manoharan M
J Med Chem; 2023 Feb; 66(4):2506-2523. PubMed ID: 36757090
[TBL] [Abstract][Full Text] [Related]
8. Investigating the pharmacodynamic durability of GalNAc-siRNA conjugates.
Brown CR; Gupta S; Qin J; Racie T; He G; Lentini S; Malone R; Yu M; Matsuda S; Shulga-Morskaya S; Nair AV; Theile CS; Schmidt K; Shahraz A; Goel V; Parmar RG; Zlatev I; Schlegel MK; Nair JK; Jayaraman M; Manoharan M; Brown D; Maier MA; Jadhav V
Nucleic Acids Res; 2020 Dec; 48(21):11827-11844. PubMed ID: 32808038
[TBL] [Abstract][Full Text] [Related]
9. Chimeric siRNAs with chemically modified pentofuranose and hexopyranose nucleotides: altritol-nucleotide (ANA) containing GalNAc-siRNA conjugates: in vitro and in vivo RNAi activity and resistance to 5'-exonuclease.
Kumar P; Degaonkar R; Guenther DC; Abramov M; Schepers G; Capobianco M; Jiang Y; Harp J; Kaittanis C; Janas MM; Castoreno A; Zlatev I; Schlegel MK; Herdewijn P; Egli M; Manoharan M
Nucleic Acids Res; 2020 May; 48(8):4028-4040. PubMed ID: 32170309
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Monovalent N-Acetylgalactosamine Phosphoramidite for Liver-Targeting Oligonucleotides.
Yamamoto T; Terada C; Kashiwada K; Yamayoshi A; Harada-Shiba M; Obika S
Curr Protoc Nucleic Acid Chem; 2019 Sep; 78(1):e99. PubMed ID: 31529782
[TBL] [Abstract][Full Text] [Related]
11. Impact of Serum Proteins on the Uptake and RNAi Activity of GalNAc-Conjugated siRNAs.
Agarwal S; Allard R; Darcy J; Chigas S; Gu Y; Nguyen T; Bond S; Chong S; Wu JT; Janas MM
Nucleic Acid Ther; 2021 Aug; 31(4):309-315. PubMed ID: 33861634
[TBL] [Abstract][Full Text] [Related]
12. Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates.
Foster DJ; Brown CR; Shaikh S; Trapp C; Schlegel MK; Qian K; Sehgal A; Rajeev KG; Jadhav V; Manoharan M; Kuchimanchi S; Maier MA; Milstein S
Mol Ther; 2018 Mar; 26(3):708-717. PubMed ID: 29456020
[TBL] [Abstract][Full Text] [Related]
13. Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of
Ayyar VS; Song D; Zheng S; Carpenter T; Heald DL
J Pharmacol Exp Ther; 2021 Nov; 379(2):134-146. PubMed ID: 34413198
[TBL] [Abstract][Full Text] [Related]
14. N-Acetylgalactosamine Block-co-Polycations Form Stable Polyplexes with Plasmids and Promote Liver-Targeted Delivery.
Dhande YK; Wagh BS; Hall BC; Sprouse D; Hackett PB; Reineke TM
Biomacromolecules; 2016 Mar; 17(3):830-40. PubMed ID: 26854615
[TBL] [Abstract][Full Text] [Related]
15. Serial incorporation of a monovalent GalNAc phosphoramidite unit into hepatocyte-targeting antisense oligonucleotides.
Yamamoto T; Sawamura M; Wada F; Harada-Shiba M; Obika S
Bioorg Med Chem; 2016 Jan; 24(1):26-32. PubMed ID: 26678173
[TBL] [Abstract][Full Text] [Related]
16. Solid-phase synthesis of 5'-triantennary N-acetylgalactosamine conjugated antisense oligonucleotides using phosphoramidite chemistry.
Prakash TP; Brad Wan W; Low A; Yu J; Chappell AE; Gaus H; Kinberger GA; Østergaard ME; Migawa MT; Swayze EE; Seth PP
Bioorg Med Chem Lett; 2015 Oct; 25(19):4127-30. PubMed ID: 26299345
[TBL] [Abstract][Full Text] [Related]
17. Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization.
Hofmeister A; Jahn-Hofmann K; Brunner B; Helms MW; Metz-Weidmann C; Krack A; Kurz M; Li Z; Weitzenberg MM; Pflimlin E; Plettenburg O; Scheidler S
J Med Chem; 2021 May; 64(10):6838-6855. PubMed ID: 33950677
[TBL] [Abstract][Full Text] [Related]
18. The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of
McDougall R; Ramsden D; Agarwal S; Agarwal S; Aluri K; Arciprete M; Brown C; Castellanos-Rizaldos E; Charisse K; Chong S; Cichocki J; Fitzgerald K; Goel V; Gu Y; Guenther D; Habtemariam B; Jadhav V; Janas M; Jayaraman M; Kurz J; Li J; Liu J; Liu X; Liou S; Maclauchlin C; Maier M; Manoharan M; Nair JK; Robbie G; Schmidt K; Smith P; Theile C; Vaishnaw A; Waldron S; Xu Y; Zhang X; Zlatev I; Wu JT
Drug Metab Dispos; 2022 Jun; 50(6):781-797. PubMed ID: 34154993
[TBL] [Abstract][Full Text] [Related]
19. Conjugation of mono and di-GalNAc sugars enhances the potency of antisense oligonucleotides via ASGR mediated delivery to hepatocytes.
Kinberger GA; Prakash TP; Yu J; Vasquez G; Low A; Chappell A; Schmidt K; Murray HM; Gaus H; Swayze EE; Seth PP
Bioorg Med Chem Lett; 2016 Aug; 26(15):3690-3. PubMed ID: 27268307
[TBL] [Abstract][Full Text] [Related]
20. Ligand Conjugated Multimeric siRNAs Enable Enhanced Uptake and Multiplexed Gene Silencing.
Brown JM; Dahlman JE; Neuman KK; Prata CAH; Krampert MC; Hadwiger PM; Vornlocher HP
Nucleic Acid Ther; 2019 Oct; 29(5):231-244. PubMed ID: 31393218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
